Mounjaro vs. Wegovy: How much weight can you lose?

 

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are potent medications that lead to significant weight reduction. We’ve broken down the key clinical trial results and what it means for your long-term success.

 

Clinical Trial Weight Loss Results

 

Clinical trials provide the best picture of the potential weight loss achievable when these drugs are combined with lifestyle changes:

• Mounjaro: Participants taking the highest dosage typically achieved an average weight loss of 22.5% of their starting body weight over approximately 1.5 years. Roughly one-third of participants achieved 20% or more weight loss.
• Wegovy: Participants taking the highest dosage typically achieved an average weight loss of approximately 15% of their starting body weight over a similar period. Roughly one-third of participants also achieved 20% or more weight loss.

The Head-to-Head Difference: In direct comparison studies, Mounjaro consistently leads to greater overall weight loss than Wegovy. For example, one major study found Mounjaro users lost 20.2% of body weight, compared to 13.7% for Wegovy users.

---

 

The Critical Role of Long-Term Commitment

 

It is crucial to emphasize that these medications are tools, not permanent cures. Experts consistently stress that Mounjaro and Wegovy work best when combined with real, sustainable lifestyle changes.

• Lifestyle is Not Optional: These drugs serve to manage appetite and cravings, making it easier to stick to a reduced-calorie diet and increased physical activity. Sustained success depends fundamentally on making those healthy habits permanent.
• The Rebound Risk: Obesity is a chronic condition, and studies indicate that when the medication is stopped, the body’s underlying biological drivers (like increased appetite and slowed metabolism) reassert themselves. This leads to significant weight regain. In one trial, participants who stopped taking Wegovy regained about two-thirds of the weight they had lost within one year.

 

How to Get the Most Out of Your Medication

 

If you are using Mounjaro or Wegovy, maximizing their effectiveness means treating them as part of a comprehensive strategy:

1. Maintain a Balanced Diet: Maximise results by ensuring your reduced-calorie intake is nutritionally balanced. Focus on lean protein, complex carbohydrates (like whole grains), and healthy fats, alongside plenty of fruits and vegetables. This prevents nutrient deficiencies and provides sustained energy.
2. Stay Hydrated and Manage GI Issues: The most common side effects are gastrointestinal. Managing nausea, constipation, or diarrhoea is key to staying on the medication. This often means increasing fiber and water intake.
3. Incorporate Strength Training: Weight loss includes muscle loss. To maintain your metabolism, ensure your physical activity includes resistance or strength training.
4. Prioritize Sleep and Stress Management: Poor sleep and chronic stress can elevate cortisol, a hormone that promotes fat storage and increases appetite, directly interfering with your weight loss goals. Aim for consistent, quality sleep and utilize stress-reduction techniques to support your overall hormonal balance.
5. Embrace Long-Term Care: Due to the risk of rebound, view the medication, or similar weight management strategies, as a potential long-term commitment that requires continuous medical guidance and support.

 

Please see a a comprehensive view of weight loss providers to get the best treatment for you.

---

 

Sources (Clinical Trials and Research)

 

1. Mounjaro (SURMOUNT-1 Trial): Tirzepatide Once Weekly for the Treatment of Obesity.Source
2. Wegovy (STEP 1 Trial): Once-Weekly Semaglutide in Adults with Overweight or Obesity.Source
3. Head-to-Head Comparison (Tirzepatide vs. Semaglutide): Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.Source
4. Weight Regain Study (STEP 1 Extension): Weight regain and cardiometabolic effects after withdrawal of semaglutide.Source